Clinical Trial Update: Effect of Pycnogenol® on ADHD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Pycnogenol® for ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention-deficit Hyperactivity Disorder

Drugs mentioned

• Pycnogenol (French maritime pine bark extract (Pinus pinaster bark extract))

Snippet

Sponsor: Nina Hermans | Conditions: ADHD | Phase 3 | Status: COMPLETED